InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,930.80
(
0.19%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
84.15
(
-0.64%
)
Bitcoin
57,946.54
(
-0.13%
)
Post# of 381786
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

georgie18

Send PM Follow Ignore
Followers 2112
Posts 91091
Boards Moderated 0
Alias Born 12/17/2011

georgie18

Member Level

Re: None

Tuesday, 01/03/2012 9:06:47 AM

Tuesday, January 03, 2012 9:06:47 AM

Post# of 381786
GNBT....news..

Generex Biotech subsidiary Antigen Express provides update on ae37 cancer vaccine's clinical & regulatory strategy


9:01 AM ET 1/3/12 | Briefing.com
Positive interim Phase 2b clinical data from the study in HER-2 expressing breast cancer subjects (presented last month at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas) has lead to an earlier-than-expected advancement in the overall development of AE37 for both breast and prostate cancer indications
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up